InvestorsHub Logo
Followers 0
Posts 139
Boards Moderated 0
Alias Born 01/08/2006

Re: mpetisth1 post# 4910

Monday, 03/12/2007 12:01:58 AM

Monday, March 12, 2007 12:01:58 AM

Post# of 6490
Also From Settlement:
In the case of an opt-in, Insmed will retain development control prior to approval, and Tercica or Genentech would gain commercial control after approval.

http://biz.yahoo.com/bw/070306/20070306006402.html?.v=1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News